Salvona Technologies
Sam Shefer has a diverse work experience starting with their role as a Research and Teaching Assistant at the Massachusetts Institute of Technology from 1990 to 1994. Sam then worked at IFF from 1994 to 1998 in their R&D department. In 1999, Sam joined Salvona Technologies as the Owner and EVP and later became the President. In 2005, they assumed the position of CEO at Salvona Technologies.
Sam Shefer's education history is as follows:
From 1983 to 1987, Sam Shefer attended Ben-Gurion University of the Negev, where they completed a BSC and MSc in Biology and BioChemistry.
In 1985, they continued their education at Ben-Gurion University of the Negev and completed a Doctor of Philosophy (PhD) in Chemical and BioChemical Engineering in 1990.
From 1991 to 1993, Sam Shefer pursued a PhD at Massachusetts Institute of Technology in the field of Chemical and BioMedical studies.
Additionally, Sam Shefer returned to Ben-Gurion University of the Negev to earn another Doctor of Philosophy (PhD) in Chemical and BioChemical Engineering, although the completion year is not specified.
Overall, Sam Shefer's education journey consisted of multiple degrees in the fields of biology, biochemistry, chemical engineering, and biomedical studies.
This person is not in the org chart
This person is not in any teams
Salvona Technologies
Salvona Technologies LLC is focused on manufacturing proprietary advanced encapsulation systems that modify the way functional and active ingredients are being delivered. These systems are used to formulate innovative and highly functional products with unique features, including long-lasting release, triggered release, and targeted delivery. The encapsulation technologies are designed to address production and application issues, such as stability of raw materials, formulation practicality, environmental and safety concerns, and user compliance. Salvona has established an umbrella of intellectual property covering its broad technology platforms that provides the company with the freedom to operate and apply these technologies in various markets including consumer health care, dermatology, pharmaceuticals, cosmetics, oral hygiene, and general consumer care. Salvona’s patent portfolio covers both the compositions and applications of its technology platforms. Since its founding, the company has applied for nearly 100 patents. Salvona is privately owned and operates in partnership with ZSCHIMMER & SCHWARZ CHEMIE GmbH.